Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options

American Journal of Medical Genetics, Part A

Volumn 149, Issue 10, 2009, Pages 2327-2338

  Elefteriou, Florent ^a   Kolanczyk, Mateusz ^b,c   Schindeler, Aaron ^d,e   Viskochil, David H ^f,g   Hock, Janet M ^h   Schorry, Elizabeth K ⁱ   Crawford, Alvin H ⁱ   Friedman, Jan M ^j   Little, David ^d,e   Peltonen, Juha ^k   Carey, John C ^f,g   Feldman, David ^l   Yu, Xijie ^h   Armstrong, Linlea ^j   Birch, Patricia ^j   Kendler, David L ^j   Mundlos, Stefan ^b,c   Yang, Feng Chun ^m   Agiostratidou, Gina ⁿ   Hunter Schaedle, Kim ⁿ   Stevenson, David A ^f,g   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e University of Sydney   (Australia)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g SHRINERS HOSPITALS FOR CHILDREN   (United States)

^h Maine Institute for Human Genetics & Health   (United States)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k UNIVERSITY OF TURKU   (Finland)

^l NYU HOSPITAL FOR JOINT DISEASES   (United States)

^m INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ Children's Tumor Foundation   (United States)

more..

Author keywords

Bone; Neurofibromatosis; NF1; Osteoblast; Osteoclast; Pseudarthrosis; Skeletal dysplasia; Tibial dysplasia

Indexed keywords

COLLAGEN;

BONE BOWING; BONE DYSPLASIA; COLLAGEN SYNTHESIS; FUNNEL CHEST; HUMAN; MACROCEPHALY; NEUROFIBROMATOSIS; NONHUMAN; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDARTHROSIS; REVIEW; SHORT STATURE; TIBIA; TIBIA FRACTURE; VERTEBRA MALFORMATION;

ANIMALS; BONE AND BONES; BONE DISEASES, DEVELOPMENTAL; DISEASE MODELS, ANIMAL; HUMANS; MICE; MODELS, BIOLOGICAL; NEUROFIBROMATOSIS 1; SPHENOID BONE; THORACIC WALL; TIBIA;

EID: 70349498475     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.33045     Document Type: Review

References (88)

1. Alwan S, Tredwell SJ, Friedman JM. 2005. Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 67:378-390. (Pubitemid 40561488)
2. Alwan S, Armstrong L, Joe H, Birch PH, Szudek J, Friedman JM. 2007. Associations of osseous abnormalities in Neurofibromatosis 1. Am J Med Genet Part A 143A:1326-1333.
3. Andersen KS. 1973. Radiological classification of congenital pseudarthrosis of the tibia. Acta Orthop Scand 44:719-727.
4. Anderson DJ, Schoenecker PL, Sheridan JJ, Rich MM. 1992. Use of an intramedullary rod for the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Am 74:161-168.
5. Bara T, Sibinski M, Synder M. 2007. Own clinical experience with functional bracing for treatment of pseudarthrosis and delayed union of the tibia. Ortop Traumatol Rehabil 9:259-263. (Pubitemid 47523222)
6. Bassett CA, Caulo N, Kort J. 1981. Congenital "pseudarthroses" of the tibia: Treatment with pulsing electromagnetic fields. Clin Orthop Relat Res 154:136-148.
7. Boyd HB. 1982. Pathology and natural history of congenital pseudarthrosis of the tibia. Clin Orthop Relat Res 166:5-13.
8. Brannan CI, Perkins AS, Vogel KS, Ratner N, Nordlund ML, Reid SW, Buchberg AM, Jenkins NA, Parada LF, Copeland NG. 1994. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8:1019-1029. (Pubitemid 24145666)
9. Brunetti-Pierri N, Doty S, Hicks J, Phan K, Mendoza-Londono R, Blazo M, Tran A, Carter S, Lewis R, Plon S, Phillips W, Smith EOB, Ellis K, Leed B. 2008. Generalized metabolic bone disease in Neurofibromatosis type 1. Mol Genet Metab 94:105-111.
10. Casselman ES, Mandell GA. 1979. Vertebral scalloping in neurofibromatosis. Radiology 131:89-94.
11. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, et al. 1990.Amajor segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193-201. (Pubitemid 20216299)
12. Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. 1999. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 135:115-117.
13. Colby RS, Saul RA. 2003. Is Jaffe-Campanacci syndrome just a manifestation of neurofibromatosis type 1? Am J Med Genet Part A 123A:60-63.
14. Coleman SS, Coleman DA. 1994. Congenital pseudarthrosis of the tibia: Treatment by transfer of the ipsilateral fibula with vascular pedicle. J Pediatr Orthop 14:156-160. (Pubitemid 24111106)
15. Crawford AH. 1986. Neurofibromatosis in children. Acta Orthop Scand Suppl 218:1-60.
16. Crawford AH Jr, Bagamery N. 1986. Osseous manifestations of neurofibromatosis in childhood. J Pediatr Orthop 6:72-88.
17. Crawford AH, Schorry EK. 1999. Neurofibromatosis in children: The role of the orthopaedist. J Am Acad Orthop Surg 7:217-230.
18. Crawford AH, Schorry EK. 2006. Neurofibromatosis update. J Pediatr Orthop 26:413-423.
19. Crawford AH, Parikh S, Schorry EK, Von Stein D. 2007. The immature spine in type-1 neurofibromatosis. J Bone Joint Surg Am 89:123-142.
20. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL. 2004. Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study. J Bone Joint Surg Am 86-A:1186-1197.
21. Dulai S, Briody J, Schindeler A, North K, Cowell C, Little D. 2007. Decreased bone mineral density in neurofibromatosis type 1: Results from a pediatric cohort. J Pediatr Orthop 27:472-475. (Pubitemid 46868318)
22. Duman O, Ozdem S, Turkkahraman D, Olgac ND, Gungor F, Haspolat S. 2008. Bone metabolism markers and bone mineral density in children with neurofibromatosis type-1. Brain Dev 30:584-588.
23. Durrani AA, Crawford AH, Chouhdry SN, Saifuddin A, Morley TR. 2000. Modulation of spinal deformities in patients with neurofibromatosis type 1. Spine 25:69-75. (Pubitemid 30035985)
24. Elefteriou F, Benson MD, Sowa H, Starbuck M, Liu X, Ron D, Parada LF, Karsenty G. 2006. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 4:441-451. (Pubitemid 44817348)
25. Friedlaender GE, Perry CR, Cole JD, Cook SD, Cierny G, Muschler GF, Zych GA, Calhoun JH, LaForte AJ, Yin S. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-:S151-158.
26. Friedman JM, Birch PH. 1997. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138-143.
27. Gilbert A, Brockman R. 1995. Congenital pseudarthrosis of the tibia. Long-term followup of 29 cases treated by microvascular bone transfer. Clin Orthop Relat Res 314:37-44.
28. Greenwood RS, Tupler LA, Whitt JK, Buu A, Dombeck CB, Harp AG, Payne ME, Eastwood JD, Krishnan KR, MacFall JR. 2005. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1. Arch Neurol 62:1904-1908. (Pubitemid 41785084)
29. Grill F, Bollini G, Dungl P, Fixsen J, Hefti F, Ippolito E, Romanus B, Tudisco C, Wientroub S. 2000. Treatment approaches for congenital pseudarthrosis of tibia: Results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 9:75-89.
30. Hardinge K. 1972. Congenital anterior bowing of the tibia. The significance of the different types in relation to pseudarthrosis. Ann R Coll Surg Engl 51:17-30.
31. Heaney RP, Weaver CM. 2005. Newer perspectives on calcium nutrition and bone quality. J Am Coll Nutr 24:574S-581S.
32. Hefti F, Bollini G, Dungl P, Fixsen J, Grill F, Ippolito E, Romanus B, Tudisco C, Wientroub S. 2000. Congenital pseudarthrosis of the tibia: History, etiology, classification, and epidemiologic data. J Pediatr Orthop B 9:11-15. (Pubitemid 30044014)
33. Illes T, Halmai V, de Jonge T, Dubousset J. 2001. Decreased bone mineral density in neurofibromatosis-1 patients with spinal deformities. Osteoporos Int 12:823-827. (Pubitemid 33086269)
34. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA. 1994. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353-361. (Pubitemid 24204410)
35. Jacquemin C, Bosley TM, Liu D, Svedberg H, Buhaliqa A. 2002. Reassessment of sphenoid dysplasia associated with neurofibromatosis type 1. Am J Neuroradiol 23:644-648. (Pubitemid 34411923)
36. Jacquemin C, Bosley TM, Svedberg H. 2003. Orbit deformities in craniofacial neurofibromatosis type 1. Am J Neuroradiol 24:1678-1682. (Pubitemid 37151740)
37. Johnson EE, Urist MR, Finerman GA. 1990. Distal metaphyseal tibial nonunion. Deformity and bone loss treated by open reduction, internal fixation, and human bone morphogenetic protein (hBMP). Clin Orthop Relat Res 250:234-240.
38. Khong PL, Goh WH, Wong VC, Fung CW, Ooi GC. 2003. MR imaging of spinal tumors in children with neurofibromatosis 1. Am J Roentgenol 180:413-417.
39. Kim HW, Weinstein SL. 1997. Spine update. The management of scoliosis in neurofibromatosis. Spine 22:2770-2776.
40. Kitoh H, Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H, Katoh M, Ishiguro N. 2004. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis - A preliminary result of three cases. Bone 35:892-898. (Pubitemid 39349220)
41. Kolanczyk M, Kossler N, Kuhnisch J, Lavitas L, Stricker S, Wilkening U, Manjubala I, Fratzl P, Sporle R, Herrmann BG, Parada L, Kornak U, Mundlos S. 2007. Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet 16:874-886. (Pubitemid 47062733)
42. Kolanczyk M, Kuehnisch J, Kossler N, Osswald M, Stumpp S, Thurisch B, Kornak U, Mundlos S. 2008. Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin. BMC Med 6:21.
43. Kuorilehto T, Nissinen M, Koivunen J, Benson MD, Peltonen J. 2004a. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos. J Bone Miner Res 19:983-989. (Pubitemid 41103455)
44. Kuorilehto T, Poyhonen M, Bloigu R, Heikkinen J, Vaananen K, Peltonen J. 2004b. Decreased bone mineral density and content in neurofibromatosis type 1: Lowest local values are located in the load-carrying parts of the body. Osteoporos Int 16:928-936. (Pubitemid 41127102)
45. Lakkis MM, Epstein JA. 1998. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125:4359-4367.
46. Lammert M, Kappler M, Mautner VF, Lammert K, Storkel S, Friedman JM, Atkins D. 2005. Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int 16:1161-1166. (Pubitemid 41225104)
47. Lammert M, Friedrich RE, Friedman JM, Mautner VF, Tucker T. 2007. Early primary tooth eruption in neurofibromatosis 1 individuals. Eur J Oral Sci 115:425-426.
48. Lee HC, Cho DY. 2006. Assessment of sacrum scalloping in neurofibromatosis type 1 caused by a giant cell lesion of the sacrum. Surg Neurol 65:194-198; discussion 198.
49. Lewiecki EM, Gordon CM, Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S, Bishop NJ, Leonard MB, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS. 2008. Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int 19:1369-1378.
50. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchell AL, Gutmann DH, Boguski M, Collins FS. 1991. cDNA cloning of the type 1 neurofibromatosis gene: Complete sequence of the NF1 gene product. Genomics 11:931-940.
51. Mimouni FB, Shamir R. 2009. Vitamin D requirements in the first year of life. Curr Opin Clin Nutr Metab Care 12:287-292.
52. Murray HH, Lovell WW. 1982. Congenital pseudarthrosis of the tibia. A long-term follow-up study. Clin Orthop Relat Res 166:14-20.
53. Ofluoglu O, Davidson RS, Dormans JP. 2008. Prophylactic bypass grafting and long-term bracing in the management of anterolateral bowing of the tibia and neurofibromatosis-1. J Bone Joint Surg Am 90:2126-2134.
54. Ohnishi I, Sato W, Matsuyama J, Yajima H, Haga N, Kamegaya M, Minami A, Sato M, Yoshino S, Oki T, Nakamura K. 2005. Treatment of congenital pseudarthrosis of the tibia: A multicenter study in Japan. J Pediatr Orthop 25:219-224. (Pubitemid 40315442)
55. Ramachandran M, Tsirikos AI, Lee J, Saifuddin A. 2004. Whole-spine magnetic resonance imaging in patients with neurofibromatosis type 1 and spinal deformity. J Spinal Disord Tech 17:483-491. (Pubitemid 40847071)
56. Rauch F, Plotkin H, DiMeglio L, Engelbert RH, Henderson RC, Munns C, Wenkert D, Zeitler P. 2008. Fracture prediction and the definition of osteoporosis in children and adolescents: The ISCD 2007 Pediatric Official Positions. J Clin Densitom 11:22-28. (Pubitemid 351602185)
57. Riccardi VM. 1999. Skeletal system. Neurofibromatosis: Phenotype, natural history, and pathogenesis. Baltimore and London: The Johns Hopkins University Press. pp 250-273.
58. Romanus B, Bollini G, Dungl P, Fixsen J, Grill F, Hefti F, Ippolito E, Tudisco C, Wientroub S. 2000. Free vascular fibular transfer in congenital pseudoarthrosis of the tibia: Results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B 9:90-93.
59. Sakamoto A, Yoshida T, Yamamoto H, Oda Y, Tsuneyoshi M, Iwamoto Y. 2007. Congenital pseudarthrosis of the tibia: Analysis of the histology and the NF1 gene. J Orthop Sci 12:361-365. (Pubitemid 47174854)
60. Schindeler A, Morse A, Harry L, Godfrey C, Mikulec K, McDonald M, Gasser JA, Little DG. 2008a. Models of tibial fracture healing in normal and Nf1-deficient mice. J Orthop Res 26:1053-1060.
61. Schindeler A, Ramachandran M, Godfrey C, Morse A, McDonald M, Mikulec K, Little DG. 2008b. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice. J Orthop Res 26:65-74.
62. Schonauer C, Tessitore E, Frascadore L, Parlato C, Moraci A. 2000. Lumbosacral dural ectasia in type 1 neurofibromatosis. Report of two cases. J Neurosurg Sci 44:165-168. discussion 169. (Pubitemid 30839452)
63. Seitz S, Schnabel C, Busse B, Schmidt HU, Beil FT, Friedrich RE, Schinke T, Mautner VF, Amling M. 2009. High bone turnover and accumulation of osteoid in patients with neurofibromatosis 1. Osteoporos Int [Epub ahead of print].
64. Stevenson DA, Birch PH, Friedman JM, Viskochil DH, Balestrazzi P, Boni S, Buske A, Korf BR, Niimura M, Pivnick EK, Schorry EK, Short MP, Tenconi R, Tonsgard JH, Carey JC. 1999. Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet 84:413-419. (Pubitemid 29239282)
65. Stevenson DA, Zhou H, Ashrafi S, Messiaen LM, Carey JC, D'Astous JL, Santora SD, Viskochil DH. 2006. Double inactivation of NF1 in tibial pseudarthrosis. Am J Hum Genet 79:143-148. (Pubitemid 43927385)
66. Stevenson DA, Moyer-Mileur LJ, Murray M, Slater H, Sheng X, Carey JC, Dube B, Viskochil DH. 2007. Bone mineral density in children and adolescents with neurofibromatosis type 1. J Pediatr 150:83-88. (Pubitemid 44937722)
67. Stevenson DA, Schwarz EL, Viskochil DH, Moyer-Mileur LJ, Murray M, Firth SD, D'Astous JL, Carey JC, Pasquali M. 2008. Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis. Pediatr Res 63:697-701.
68. Szudek J, Birch P, Friedman JM. 2000. Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 37:933-938. (Pubitemid 32002890)
69. Tashjian AH Jr, Gagel RF. 2006. Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21:354-365.
70. Traub JA, O'Connor W, Masso PD. 1999. Congenital pseudarthrosis of the tibia: A retrospective review. J Pediatr Orthop 19:735-738.
71. Tubbs RS, Oakes WJ. 2002. Dural ectasia in neurofibromatosis. Pediatr Neurosurg 37:331-332.
72. Tucker T, Birch P, Savoy DM, Friedman JM. 2007. Increased dental caries in people with neurofibromatosis 1. Clin Genet 72:524-527. (Pubitemid 350131056)
73. Tucker T, Schnabel C, Hartmann M, Friedrich R, Frieling I, Kruse HP, Mautner VF, Friedman JM. 2008. Bone health and fracture rate in individuals with NF1. J Med Genet 46:259-265.
74. Tudisco C, Bollini G, Dungl P, Fixen J, Grill F, Hefti F, Romanus B, Wientroub S. 2000. Functional results at the end of skeletal growth in 30 patients affected by congenital pseudoarthrosis of the tibia. J Pediatr Orthop B 9:94-102. (Pubitemid 30253774)
75. Vander Have KL, Hensinger RN, Caird M, Johnston C, Farley FA. 2008. Congenital pseudarthrosis of the tibia. J Am Acad Orthop Surg 16:228-236.
76. Virdis R, Street ME, Bandello MA, Tripodi C, Donadio A, Villani AR, Cagozzi L, Garavelli L, Bernasconi S. 2003. Growth and pubertal disorders in neurofibromatosis type 1. J Pediatr Endocrinol Metab 16:289-292. (Pubitemid 37259064)
77. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, et al. 1990. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187-192. (Pubitemid 20216298)
78. Visnapuu V, Peltonen S, Ellila T, Kerosuo E, Vaananen K, Happonen RP, Peltonen J. 2007. Periapical cemental dysplasia is common in women with NF1. Eur J Med Genet 50:274-280. (Pubitemid 47058416)
79. Vitale MG, Guha A, Skaggs DL. 2002. Orthopaedic manifestations of neurofibromatosis in children: An update. Clin Orthop Relat Res 401:107-118. (Pubitemid 34832841)
80. von Satzger G, Herbst E. 1981. Surgical and electrical methods in the treatment of congenital and posttraumatic pseudarthrosis of the tibia. Clin Orthop Relat Res 161:82-104. (Pubitemid 12202249)
81. Wagner CL, Greer FR. 2008. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 122:1142-1152.
82. Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. 2004. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res 19:360-369. (Pubitemid 38787390)
83. Wientroub S, Grill F. 2000. Congenital pseudarthrosis of the tibia: Part 1. European Pediatric Orthopaedic Society multicenter study of congenital pseudoarthrosis. J Pediatr Orthop B 9:1-2.
84. Yan J, Chen S, Zhang Y, Li X, Li Y, Wu X, Yuan J, Robling AG, Karpur R, Chan RJ, Yang FC. 2008. Rac1 mediates the osteoclast gains-infunction induced by haploinsufficiency of Nf1. Hum Mol Genet 17:936-948.
85. Yang FC, Chen S, Clegg T, Li X, Morgan T, Estwick SA, Yuan J, Khalaf W, Burgin S, Travers J, Parada LF, Ingram DA, Clapp DW. 2006a. Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum Mol Genet 15:2421-2437. (Pubitemid 44288696)
86. Yang FC, Chen S, Robling AG, Yu X, Nebesio TD, Yan J, Morgan T, Li X, Yuan J, Hock J, Ingram DA, Clapp DW. 2006b. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions. J Clin Invest 116:2880-2891. (Pubitemid 44684473)
87. Yilmaz K, Ozmen M, Bora Goksan S, Eskiyurt N. 2007. Bone mineral density in children with neurofibromatosis 1. Acta Paediatr 96:1220-1222.
88. Yu X, Chen S, Potter OL, Murthy SM, Li J, Pulcini JM, Ohashi N, Winata T, Everett ET, Ingram D, Clapp WD, Hock JM. 2005. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning. Bone 36:793-802. (Pubitemid 40616014)